Reference is made to the stock exchange notice from Aqua Bio Technology ASA ("ABTEC" or the "Company") published on 13 March 2026 regarding the Extraordinary General Meeting approving a NOK 50 million debt conversion with the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a subscription price of NOK 5.00 per New Share (the "Debt Conversion”).
The following primary insiders or close associates of primary insiders have subscribed for and been allocated New Shares:
· Norlane AS, a company controlled by ABTEC chairman Roger Sedal, has been allocated 1,662,162 New Shares in the Debt Conversion, for a total subscription amount of NOK 8,310,810. Following this and upon completion of the Debt Conversion, Norlane AS will hold 1,828,368 shares in the Company, corresponding to 12.0% of the shares and votes in the Company; and
· Terabyte Holding AS, a company controlled by ABTEC board member Terje Blytt, has been allocated 2,310,811 New Shares in the Debt Conversion, for a total subscription amount of NOK 11,554,055. Following this and upon completion of the Debt Conversion, Terabyte Holding AS will hold 2,638,211 shares in the Company, corresponding to 17.3% of the shares and votes in the Company
Please see the attached notification forms for further information.
The calculations in this notice are based on a total number of shares in the Company of 15,227,935 following completion of the Debt Conversion, and registration of the shares in the Norwegian Register of Business Enterprises.
This information is subject to the disclosure requirements pursuant to MAR article 19.